Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-10

FDA Approved: ERLOTINIB HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved the original ANDA for erlotinib hydrochloride (generic) from Novadoz Pharmaceuticals LLC, making a generic version available for the same indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erlotinib hydrochloride (Erlotinib)

Snippet

ORIG AP for ERLOTINIB HYDROCHLORIDE (ERLOTINIB HYDROCHLORIDE)